MRF-Logo2019-Horizontal-RGB
FDA Approves Ipilimumab for Stage III Melanoma Patients
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

FDA Approves Ipilimumab for Stage III Melanoma Patients

› Forums › General Melanoma Community › FDA Approves Ipilimumab for Stage III Melanoma Patients

  • Post
Viewing 8 reply threads
  • Replies
      • October 28, 2015 at 11:51 pm
      geriakt
      Participant

        Wow, I was not expecting that.  I wonder if BMS will cancel my Clinical trial for IPI/NIVO now as there really is no need? Quite honestly it would be cheaper to me to quit my trial and just get the Yervoy as my yearly out of pocket has been met. 

        Tom

        • October 28, 2015 at 11:51 pm
        geriakt
        Participant

          Wow, I was not expecting that.  I wonder if BMS will cancel my Clinical trial for IPI/NIVO now as there really is no need? Quite honestly it would be cheaper to me to quit my trial and just get the Yervoy as my yearly out of pocket has been met. 

          Tom

          • October 28, 2015 at 11:51 pm
          geriakt
          Participant

            Wow, I was not expecting that.  I wonder if BMS will cancel my Clinical trial for IPI/NIVO now as there really is no need? Quite honestly it would be cheaper to me to quit my trial and just get the Yervoy as my yearly out of pocket has been met. 

            Tom

            • October 29, 2015 at 12:22 am
            jenny22
            Participant

              It is great news, but i can't help but wonder now…..

              Had instranist recurrrence last NOV, complete resection…..never was able to have SNB …..DOCS all  "assuming" negative node status…..now making me stage IIIB….had vaccine trial at NYU Feb- May……

              Now wonder if IPI would have been better……Being treated at NYU, with ANNA Pavlick…love her….

              Just wondering if something to ask about.

               

              Thoughts anyone????

               

              TKs,

              • October 29, 2015 at 12:22 am
              jenny22
              Participant

                It is great news, but i can't help but wonder now…..

                Had instranist recurrrence last NOV, complete resection…..never was able to have SNB …..DOCS all  "assuming" negative node status…..now making me stage IIIB….had vaccine trial at NYU Feb- May……

                Now wonder if IPI would have been better……Being treated at NYU, with ANNA Pavlick…love her….

                Just wondering if something to ask about.

                 

                Thoughts anyone????

                 

                TKs,

                • October 29, 2015 at 12:22 am
                jenny22
                Participant

                  It is great news, but i can't help but wonder now…..

                  Had instranist recurrrence last NOV, complete resection…..never was able to have SNB …..DOCS all  "assuming" negative node status…..now making me stage IIIB….had vaccine trial at NYU Feb- May……

                  Now wonder if IPI would have been better……Being treated at NYU, with ANNA Pavlick…love her….

                  Just wondering if something to ask about.

                   

                  Thoughts anyone????

                   

                  TKs,

                  • October 29, 2015 at 12:55 am
                  jamieth29
                  Participant
                    Here is something to think about that my oncologist Dr Jason Luke had about ipi as adjuvant. Ipi has shown a 25% success rate as an adjuvant and a 22% success rate in stage 4. He sees no statistical advantage to taking it as adjuvant because the side effects can be severe. His opinion is why put yourself through the chance of immune related events when there is a chance the cancer may not return. If it does you statistically have the same chance of responding. I hope the pd-1 drugs show a much better efficacy as adjuvant therapy which remains to be seen.
                      • November 4, 2015 at 8:02 pm
                      jenny22
                      Participant

                        Hi Janieth29-

                        Intereresting point made by your oncologist……I am hearing similar things…..just met with Dr. Coit, surgical oncologist at MSKCC…..i asked him his opintion and he said he thinks IPI will be a "tough sell" in the adjuvant setting due to the extremely high toxity profile……he is hopeful that PD1 treatments will soon be an option without the IPI side effects……my MEd. ONC also seems hesitant on IPI for me in this setting….

                        In spite of all this, I feel the need to do SOMETHING to ZAP any cells that may be flaoting aorund somewhere…..after 2 recurrences it is scary to wonder where they are going next….Radiation is a good alternative for local "Stuff', but the goal is to keep it from going anywhere else!

                        Lets hope we soon have some other options for adjuvant treatments.

                         

                        Best,

                        jenny

                        • November 4, 2015 at 8:02 pm
                        jenny22
                        Participant

                          Hi Janieth29-

                          Intereresting point made by your oncologist……I am hearing similar things…..just met with Dr. Coit, surgical oncologist at MSKCC…..i asked him his opintion and he said he thinks IPI will be a "tough sell" in the adjuvant setting due to the extremely high toxity profile……he is hopeful that PD1 treatments will soon be an option without the IPI side effects……my MEd. ONC also seems hesitant on IPI for me in this setting….

                          In spite of all this, I feel the need to do SOMETHING to ZAP any cells that may be flaoting aorund somewhere…..after 2 recurrences it is scary to wonder where they are going next….Radiation is a good alternative for local "Stuff', but the goal is to keep it from going anywhere else!

                          Lets hope we soon have some other options for adjuvant treatments.

                           

                          Best,

                          jenny

                          • November 4, 2015 at 8:02 pm
                          jenny22
                          Participant

                            Hi Janieth29-

                            Intereresting point made by your oncologist……I am hearing similar things…..just met with Dr. Coit, surgical oncologist at MSKCC…..i asked him his opintion and he said he thinks IPI will be a "tough sell" in the adjuvant setting due to the extremely high toxity profile……he is hopeful that PD1 treatments will soon be an option without the IPI side effects……my MEd. ONC also seems hesitant on IPI for me in this setting….

                            In spite of all this, I feel the need to do SOMETHING to ZAP any cells that may be flaoting aorund somewhere…..after 2 recurrences it is scary to wonder where they are going next….Radiation is a good alternative for local "Stuff', but the goal is to keep it from going anywhere else!

                            Lets hope we soon have some other options for adjuvant treatments.

                             

                            Best,

                            jenny

                          • October 29, 2015 at 12:55 am
                          jamieth29
                          Participant
                            Here is something to think about that my oncologist Dr Jason Luke had about ipi as adjuvant. Ipi has shown a 25% success rate as an adjuvant and a 22% success rate in stage 4. He sees no statistical advantage to taking it as adjuvant because the side effects can be severe. His opinion is why put yourself through the chance of immune related events when there is a chance the cancer may not return. If it does you statistically have the same chance of responding. I hope the pd-1 drugs show a much better efficacy as adjuvant therapy which remains to be seen.
                            • October 29, 2015 at 12:55 am
                            jamieth29
                            Participant
                              Here is something to think about that my oncologist Dr Jason Luke had about ipi as adjuvant. Ipi has shown a 25% success rate as an adjuvant and a 22% success rate in stage 4. He sees no statistical advantage to taking it as adjuvant because the side effects can be severe. His opinion is why put yourself through the chance of immune related events when there is a chance the cancer may not return. If it does you statistically have the same chance of responding. I hope the pd-1 drugs show a much better efficacy as adjuvant therapy which remains to be seen.
                          Viewing 8 reply threads
                          • You must be logged in to reply to this topic.
                          About the MRF Patient Forum

                          The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                          The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                          Popular Topics